Dalibalta Sarah, Majdalawieh Amin F, Manjikian Herak
Department of Biology, Chemistry, and Environmental Sciences, Faculty of Arts and Sciences, American University of Sharjah, Sharjah, P.O. Box 26666, United Arab Emirates.
Saudi Pharm J. 2020 Oct;28(10):1276-1289. doi: 10.1016/j.jsps.2020.08.018. Epub 2020 Sep 1.
Sesamin, a major lignin isolated from sesame () seeds and sesame oil, is known to possess antioxidant and anti-inflammatory properties. Several studies have revealed that oxidative stress and inflammation play a major role in a variety of cardiovascular diseases (CVDs). This comprehensive review summarizes the evidence on the effects of sesamin on CVD and its risk factors, principally due to its antioxidant properties. Specifically, this review highlights the mechanisms underlying the anti-hypertensive, anti-atherogenic, anti-thrombotic, anti-diabetic, and anti-obesity, lipolytic effects of sesamin both and , and identifies the signaling pathways targeted by sesamin and its metabolites. The data indicates that RAS/MAPK, PI3K/AKT, ERK1/2, p38, p53, IL-6, TNFα, and NF-κB signaling networks are all involved in moderating the various effects of sesamin on CVD and its risk factors. In conclusion, the experimental evidence suggesting that sesamin can reduce CVD risk is convincing. Thus, sesamin can be potentially useful as an adjuvant therapeutic agent to combat CVD and its multitude of risk factors.
芝麻素是从芝麻籽和芝麻油中分离出的一种主要木脂素,已知具有抗氧化和抗炎特性。多项研究表明,氧化应激和炎症在多种心血管疾病(CVD)中起主要作用。这篇综述总结了芝麻素对CVD及其危险因素影响的证据,主要归因于其抗氧化特性。具体而言,本综述强调了芝麻素在体内和体外的抗高血压、抗动脉粥样硬化、抗血栓形成、抗糖尿病和抗肥胖、脂解作用的潜在机制,并确定了芝麻素及其代谢产物靶向的信号通路。数据表明,RAS/MAPK、PI3K/AKT、ERK1/2、p38、p53、IL-6、TNFα和NF-κB信号网络均参与调节芝麻素对CVD及其危险因素的各种作用。总之,表明芝麻素可降低CVD风险的实验证据令人信服。因此,芝麻素作为对抗CVD及其众多危险因素的辅助治疗剂可能具有潜在用途。